Product
Supplier
Encyclopedia
Inquiry
Home > News > Policy & Regulation
ECHEMI chemical news

Policy & Regulation

South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%

South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%

2026-07-24

South Korea has moved from negotiation to implementation on a major petrochemical restructuring plan. On July 22, 2026, the government approved the “Yeosu No. 1” proposal from Yeochun NCC, Lotte Chemical, Hanwha Solutions, and DL Chemical. The plan merges selected naphtha-cracking and downstream operations while shutting Yeochun NCC’s No. 2 and No. 3 crackers, removing 1.39 million metric tons of ethylene capacity—about 40% of the participants’ combined NCC capacity. This marks one of South Kore

U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End

U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End

2026-07-21

FDA has moved the planned GRAS mandatory-notification proposal to December 2026, leaving the voluntary system intact for now while signaling that ingredient suppliers should prepare for substantially greater disclosure and documentation requirements.

China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle

China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle

2026-07-16

China’s carbon-peaking plan does not eliminate coal chemicals, but turns low-carbon performance into a hard condition for future approvals, expansion, financing and international competitiveness.

U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years

U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years

2026-07-15

The two-year exemption protects critical U.S. chemical supply chains in the near term, but postpones rather than resolves the conflict between industrial security, technical feasibility and hazardous-emissions control.

Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price

Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price

2026-07-14

Trutakna’s FDA approval gives Vera Therapeutics a first-in-class position in IgA nephropathy, but its $425,000 annual price and reliance on a surrogate endpoint will keep clinical value and reimbursement under close scrutiny.

Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.

Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.

2026-07-14

Bayer and Syngenta have gained valuable U.S. protection for glyphosate, dicamba and atrazine, improving commercial visibility while leaving the underlying health and environmental disputes unresolved.

South Korea Expands Mandatory GMO Labeling to Highly Processed Foods

South Korea Expands Mandatory GMO Labeling to Highly Processed Foods

2026-07-14

South Korea’s expanded GMO labeling framework shifts the focus from detectable genetic material to raw-material origin, raising traceability and sourcing requirements across the processed-food supply chain.

Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire

Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire

2026-07-07

In early July, mainstream refrigerant prices in China hit new decade highs. R32 surged over 320% year-on-year to RMB 64,000/ton, while R134a reached the same level, up 30% year-on-year. R22 rose 28% in 2026. The price rally is driven by China's strict production quota system under the Montreal Protocol and Kigali Amendment. HFC quotas are capped through 2026, and R22 quotas continue to shrink. With the top six producers controlling nearly 90% of the market, supply remains tight. Routine maintena

Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger

Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger

2026-07-07

Medicare’s $50 GLP-1 program could sharply expand U.S. weight-loss drug access while increasing pressure on pharma supply chains, reimbursement systems and even food-sector product strategy.

China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot

China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot

2026-07-07

Hybio’s FDA-reviewed generic tirzepatide applications show that Chinese peptide-drug companies are starting to challenge the future structure of the global GLP-1 market.

FDA Warning Letters Put GMP Back in Focus

FDA Warning Letters Put GMP Back in Focus

2026-07-07

FDA warning letters show that GMP, documentation and inspection readiness remain central to pharmaceutical market access.

FDA Fast-Tracks U.S. Drug Manufacturing

FDA Fast-Tracks U.S. Drug Manufacturing

2026-07-07

FDA’s PreCheck pilot shows the U.S. is pushing harder to bring strategic drug manufacturing capacity closer to home.

关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances

关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances

2026-06-26

根据《麻醉药品和精神药品管理条例》等规定,公安部、国家卫健委和药监局决定将二氟乙咪酯等16种物质列入非药用类麻醉药品和精神药品目录。本次列管的替来他明不含已批准上市的兽用麻醉药品。该公告自2026年7月1日起施行。ECHEMI平台提醒用户遵守国家法规,违规商品将被下架并受相应处罚。

Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion

Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion

2026-06-26

On June 21, four key units of the Huajin Aramco Fine Chemicals and Raw Materials Project in Panjin, Liaoning, reached mechanical completion. These include a 200,000 t/y HDPE unit, a 590,000 t/y EO/EG unit, a 300,000 t/y PO unit, and a 200,000 t/y polyether polyols unit. This milestone transitions the project from construction to commissioning. The overall project, a Sino-Saudi Belt and Road initiative, involves RMB 83.7 billion investment and 32 process units. Construction began in March 2023, w

FDA Dye Tracker Raises Reformulation Pressure Across Food Brands

FDA Dye Tracker Raises Reformulation Pressure Across Food Brands

2026-06-19

FDA’s dye tracker may accelerate clean-label reformulation across major U.S. food categories.

GM Crop Area Reaches 216 Million Hectares

GM Crop Area Reaches 216 Million Hectares

2026-06-16

Record GM crop acreage is tightening the link between seed traits and crop-protection demand.

FDA Delays Beetroot Red and Spirulina Color Orders

FDA Delays Beetroot Red and Spirulina Color Orders

2026-06-16

FDA’s delay adds uncertainty to natural color approvals and food reformulation plans.

FDA Pushes New Approach to “No Artificial Colors” Claims

FDA Pushes New Approach to “No Artificial Colors” Claims

2026-06-16

FDA’s claim policy may accelerate clean-label reformulation across U.S. food products.

GM Crop Area Reaches 216 Million Hectares

GM Crop Area Reaches 216 Million Hectares

2026-06-13

Record GM crop acreage is tightening the link between seed traits and crop-protection demand.

FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens

FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens

2026-06-11

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol (BEMT) as a new active ingredient for over-the-counter sunscreens, the first new UV filter added to the U.S. sunscreen monograph in over 20 years. Already popular in Europe and Asia, bemotrizinol offers broad-spectrum protection against UVA and UVB rays, high photostability, and low skin absorption. It is considered generally recognized as safe and effective for adults and children aged six months and older. The ingredient can

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.